Psichogiou, M.; Karabinis, A.; Poulakou, G.; Antoniadou, A.; Kotanidou, A.; Degiannis, D.; Pavlopoulou, I.D.; Chaidaroglou, A.; Roussos, S.; Mastrogianni, E.;
et al. Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection. Vaccines 2021, 9, 1017.
https://doi.org/10.3390/vaccines9091017
AMA Style
Psichogiou M, Karabinis A, Poulakou G, Antoniadou A, Kotanidou A, Degiannis D, Pavlopoulou ID, Chaidaroglou A, Roussos S, Mastrogianni E,
et al. Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection. Vaccines. 2021; 9(9):1017.
https://doi.org/10.3390/vaccines9091017
Chicago/Turabian Style
Psichogiou, Mina, Andreas Karabinis, Garyphallia Poulakou, Anastasia Antoniadou, Anastasia Kotanidou, Dimitrios Degiannis, Ioanna D. Pavlopoulou, Antigoni Chaidaroglou, Sotirios Roussos, Elpida Mastrogianni,
and et al. 2021. "Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection" Vaccines 9, no. 9: 1017.
https://doi.org/10.3390/vaccines9091017
APA Style
Psichogiou, M., Karabinis, A., Poulakou, G., Antoniadou, A., Kotanidou, A., Degiannis, D., Pavlopoulou, I. D., Chaidaroglou, A., Roussos, S., Mastrogianni, E., Eliadi, I., Basoulis, D., Petsios, K., Leontis, K., Kakalou, E., Protopapas, K., Jahaj, E., Pratikaki, M., Syrigos, K. N.,
... Hatzakis, A.
(2021). Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection. Vaccines, 9(9), 1017.
https://doi.org/10.3390/vaccines9091017
